Fig. 1From: Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk diseaseBoosting immune response through blocking inhibitory pathways and activating immune cells. HMA: hypomethylating agents; APC: antigen-presenting cell; MHC: Major histocompatibility complex. Created with BioRenders.comBack to article page